“…The WHO Nomenclature Committee for Factors of the HLA System met at the ASHI conference in Vancouver, Canada, on October 10th, 1998, to consider additions and revisions to the nomenclature of specificities defined by both molecular and serological techniques following the principles established in previous reports [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14]. …”